Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Effects of SGLT2 Inhibitors on Pericoronary Fat in Non-diabetic ACS Patients Without Heart Failure Using CCTA

NCT07351643 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT07351643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07351643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Effects of SGLT2 Inhibitors on Pericoronary Fat in Non-diabetic ACS Patients Without Heart Failure Using CCTA
Lead sponsor
Shenyang Northern Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 25, 2026
Completion date
December 30, 2026
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acs (acute coronary syndrome), sglt2 inhibitors